Impaired Binding to Junctophilin-2 and Nanostructural Alteration in CPVT Mutation
Author | Yin, Liheng |
Author | Jr, Alexandra Zahradnikova |
Author | Rizzetto, Riccardo |
Author | Boncompagni, Simona |
Author | Meritens, Camille Rabesahala de |
Author | Zhang, Yadan |
Author | Joanne, Pierre |
Author | Marqués-Sulé, Elena |
Author | Aguilar-Sánchez, Yuriana |
Author | Fernández-Tenorio, Miguel |
Author | Villejoubert, Olivier |
Author | Li, Linwei |
Author | Wang, Yue Yi |
Author | Mateo, Philippe |
Author | Nicolas, Valérie |
Author | Gerbaud, Pascale |
Author | Lai, F. Anthony |
Author | Perrier, Romain |
Author | Álvarez, Julio L. |
Author | Niggli, Ernst |
Author | Valdivia, Héctor H. |
Author | Valdivia, Carmen R. |
Author | Ramos-Franco, Josefina |
Author | Zorio, Esther |
Author | Zissimopoulos, Spyros |
Author | Protasi, Feliciano |
Author | Benitah, Jean-Pierre |
Author | Gómez, Ana M. |
Available date | 2021-08-08T10:12:04Z |
Publication Date | 2021-07-23 |
Publication Name | Circulation Research |
Identifier | http://dx.doi.org/10.1161/CIRCRESAHA.121.319094 |
Abstract | RATIONALE: Catecholaminergic polymorphic ventricular tachycardia is a rare disease, manifested by syncope or sudden death in children or young adults under stress conditions. Mutations in the Ca2+ release channel/type 2 ryanodine receptor (RyR2) gene account for about 60% of the identified mutations. Recently, we found and described a mutation in RyR2 N-terminal domain, RyR2R420Q. OBJECTIVE: To determine the arrhythmogenic mechanisms of this mutation. METHODS AND RESULTS: Ventricular tachycardias under stress conditions were observed in both patients with catecholaminergic polymorphic ventricular tachycardia and knock-in mice. During action potential recording (by patch-clamp in knock-in mouse cardiomyocytes and by microelectrodes in mutant human induced pluripotent stem cell-derived cardiomyocytes), we observed an increased occurrence of delayed afterdepolarizations under isoproterenol stimulation, associated with increased Ca2+ waves during confocal Ca2+ recording in both mouse and human RyR2R420Q cardiomyocytes. In addition, Ca2+-induced Ca2+-release, as well as a rough indicator of fractional Ca2+ release, were higher and Ca2+ sparks longer in the RyR2R420Q-expressing cells. At the ultrastructural nanodomain level, we observed smaller RyR2 clusters and widened junctional sarcoplasmic reticulum measured by gated stimulated emission depletion super-resolution and electronic microscopy, respectively. The increase in junctional sarcoplasmic reticulum width might be due to the impairment of RyR2R420Q binding to junctophilin-2, as there were less junctophilin-2 coimmunoprecipitated with RyR2R420Q. At the single current level, the RyR2R420Q channel dwells longer in the open state at low intracellular Ca2+ ([Ca2+]i), but there is predominance of a subconductance state. The latter might be correlated with an enhanced interaction between the N terminus and the core solenoid, a RyR2 interdomain association that has not been previously implicated in the pathogenesis of arrhythmias and sudden cardiac death. CONCLUSIONS: The RyR2R420Q catecholaminergic polymorphic ventricular tachycardia mutation modifies the interdomain interaction of the channel and weakens its association with junctophillin-2. These defects may underlie both nanoscale disarrangement of the dyad and channel dysfunction. GRAPHIC ABSTRACT: An online graphic abstract is available for this article. |
Sponsor | This work was funded by Inserm and University Paris-Sud, and grants from ANR (ANR-19-CE14-0031-01 to A.M. Gómez), LabEx LERMIT (ANR-10-LABX-33), “Instituto de Salud Carlos III”; FEDER “Union Europea, Una forma de hacer Europa” (PI18/01582), La Fe Biobank (PT17/0015/0043) and Memorial Nacho Barberá to E. Zorio; Swiss National Science Foundation (SNSF grants no. 31003A 179325 and 310030 156375 to E. Niggli), British Heart Foundation (FS/15/30/31494) to S. Zissimopoulos; Italian Telethon ONLUS Foundation (GGP19231) and Italian MIUR (PRIN no. 2015ZZR4W3) to F. Protasi; National Institutes of Health (NIH) grants to J. Ramos-Franco (R01GM111397) and H.H. Valdivia–A.M. Gómez (2R01HL055438-22); and European Union H2020 (MSCA-RISE AMD-734931- 6) to A.M. Gómez. H.H. Valdivia was recipient of a Fullbright-Tockeville chair to work on A.M. Gómez laboratory. J.L. Álvarez and C.R. Valdivia were recipient of a visiting program Alambert from University Paris-Sud to work in A.M. Gómez laboratory. A. Zahradnikova was recipient of a postdoctoral position from University Paris-Sud. R. Rizzetto was recipient of a postdoctoral fellowship from CORDDIM (Région Ile de France). L. Yin was recipient of the CSC (Chinese Scholarship council). |
Language | en |
Publisher | American Heart Association |
Subject | ryanodine receptor ventricular tachycardia action potential calcium junctophilin mutation |
Type | Article |
Issue Number | 3 |
Volume Number | 129 |
Files in this item
Files | Size | Format | View |
---|---|---|---|
There are no files associated with this item. |
This item appears in the following Collection(s)
-
Medicine Research [1508 items ]